Monday, 01 March 2021

PerkinElmer India receives CDSCO approval for COVID-19 test

11 June 2020 | News

This test is intended to help meet the heightened needs for COVID-19 testing in India

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that PerkinElmer India has received commercial approval by the Central Drugs Standard Control Organization (CDSCO) for the PerkinElmer New Coronavirus Nucleic Acid Detection Kit. This test is intended to help meet the heightened needs for COVID-19 testing in India.

PerkinElmer’s RT-PCR test received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). It is also marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is now available in over 30 countries worldwide.

“COVID-19 continues to have a significant impact in India and it is imperative that testing facilities have the kits on hand to identify cases without delay. Receiving CDSCO approval for our RT-PCR test will bolster the solutions available to testing facilities across India and help toward improving health outcomes,” said Shripad Joshi, Director, India and South Asia, PerkinElmer.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls